Stage IIIA non-small cell lung cancer: Morbidity and mortality of three distinct multimodality regimens

Annals of Thoracic Surgery

Volumn 95, Issue 5, 2013, Pages 1708-1716

  Seder, Christopher W ^a   Allen, Mark S ^a   Cassivi, Stephen D ^a   Deschamps, Claude ^a   Nichols, Francis C ^a   Olivier, Kenneth R ^a   Shen, K Robert ^a   Wigle, Dennis A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANEMIA; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DEEP VEIN THROMBOSIS; DEHYDRATION; DERMATITIS; ESOPHAGITIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PALLIATIVE THERAPY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; REFERENCE DATABASE; STEREOTACTIC BODY RADIATION THERAPY; THORACOTOMY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING;

EID: 84876674945     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.02.041     Document Type: Article

References (20)

1. Surveillance, epidemiology and end results: US National Institutes of Health 2010 National Cancer Institute Bethesda, MD
2. A.A. Shah, M.F. Berry, C. Tzao et al. Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer Ann Thorac Surg 93 2012 1807 1812
3. K.S. Albain, R.S. Swann, V.W. Rusch et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
4. K.S. Albain, V.W. Rusch, J.J. Crowley et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805 J Clin Oncol 13 1995 1880 1892
5. V.W. Rusch, D.J. Giroux, M.J. Kraut et al. Induction chemoradiation and surgical resection for superior sulcus non-small cell lung carcinomas: long-term results of Southwest Oncology group Trial 9416 (Intergroup Trial 0160) J Clin Oncol 25 2007 313 318
6. W.C. Fowler, C.J. Langer, W.J. Curran Jr., S.M. Keller Postoperative complications after combined neoadjuvant treatment of lung cancer Ann Thorac Surg 55 1993 986 989
7. K.M. Pisters, M.G. Kris, R.J. Gralla, M.B. Zaman, R.T. Heelan, N. Martini Pathologic complete response in advanced non-small cell lung cancer following preoperative chemotherapy: implications for the design of future non-small cell lung cancer combined modality trials J Clin Oncol 11 1993 1757 1762
8. R. Bueno, W.G. Richards, S.J. Swanson et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 2000 1826 1831
9. M. Suntharalingam, J.R. Sonett, M.L. Haas et al. The use of concurrent chemotherapy with high dose radiation before surgical resection in patients presenting with apical sulcus tumors Cancer J 6 2000 365 371
10. R.J. Cerfolio, A.S. Bryant, V.L. Jones, R.M. Cerfolio Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival Eur J Cardiothorac Surg 35 2009 718 723
11. M. Suntharalingum, R. Paulus, M.J. Edelman et al. RTOG 0229: A phase II trial of neoadjuvant therapy with concurrent chemotherapy and high-dose radiotherapy (XRT) followed by resection and consolidative therapy for LA-NSCLC J Clin Oncol 28 2010 15s
12. J.R. Sonnett, M. Suntharalingam, M.J. Edelman et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small cell lung cancer Ann Thorac Surg 78 2004 1200 1206
13. N.K. Veeramachaneni, R.H. Feins, B.J. Stephenson, L.J. Edwards, F.G. Fernandez Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America Ann Thorac Surg 94 2012 922 928
14. NCCN Guidelines Version 2. 2013; Non-Small Cell Lung Cancer. Available at www.nccn.org/professionals/physician-gls/pdf/nsclc.pdf. Accessed January 19, 2013.
15. M. Pijls-Johannesma, R. Houben, L. Boersma et al. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL Radiother Oncol 91 2009 443 448
16. M. Machtay, C. Hsu, R. Komaki et al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience Int J Radiat Oncol Biol Phys 63 2005 667 671
17. M. Liberman, S.D. Cassivi Bronchial stump dehiscence: update on prevention and management Semin Thorac Cardiovasc Surg 19 2007 366 373
18. N.C. Choi, J.A. Doucette Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach Cancer 48 1981 101 109
19. C.A. Perez, K. Stanley, G. Grundy et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung Cancer 50 1982 1091 1099
20. C.A. Perez, T.F. Pajak, P. Rubin et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group Cancer 59 1987 1874 1881